Key Points
- Tempus AI CEO Eric Lefkofsky sold 166,250 shares on June 29 at an average price of $57.48, for total proceeds of about $9.56 million. The sale reduced his direct ownership by 1.86% and was made under a pre-arranged Rule 10b5-1 trading plan.
- The company’s recent quarterly results beat expectations, with EPS of -$0.13 versus the -$0.21 consensus and revenue of $348.12 million, up 36.1% year over year. Even so, Tempus AI remains unprofitable, and analysts expect a full-year loss.
- Wall Street sentiment is mixed but leans cautious, with nine Buy ratings, four Holds, and two Sells, and an average target price of $68.54. Recent insider selling and a lowered target from some analysts have pressured sentiment, even as some firms remain bullish on the growth story.
Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric Lefkofsky sold 166,250 shares of the firm's stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $57.48, for a total transaction of $9,556,050.00. Following the completion of the transaction, the chief executive officer directly owned 8,775,283 shares in the company, valued at $504,403,266.84. This represents a 1.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Tempus AI Price Performance
NASDAQ:TEM opened at $61.60 on Thursday. Tempus AI, Inc. has a 12 month low of $41.73 and a 12 month high of $104.32. The stock has a 50 day moving average of $50.28 and a two-hundred day moving average of $54.60. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96. The firm has a market cap of $11.06 billion, a P/E ratio of -35.81 and a beta of 3.45.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.08. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. During the same period in the previous year, the company posted ($0.24) earnings per share. The business's revenue was up 36.1% on a year-over-year basis. On average, analysts expect that Tempus AI, Inc. will post -1.35 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Guggenheim reduced their target price on shares of Tempus AI from $95.00 to $60.00 and set a "buy" rating for the company in a research report on Monday, March 30th. HC Wainwright dropped their price objective on shares of Tempus AI from $95.00 to $64.00 and set a "buy" rating for the company in a research note on Monday, May 11th. TD Cowen increased their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the company a "buy" rating in a report on Wednesday, May 6th. Weiss Ratings reissued a "sell (e+)" rating on shares of Tempus AI in a research note on Wednesday, June 17th. Finally, Wall Street Zen upgraded Tempus AI from a "sell" rating to a "hold" rating in a report on Saturday, June 6th. Nine research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $68.54.
View Our Latest Stock Analysis on TEM
Tempus AI News Roundup
Here are the key news stories impacting Tempus AI this week:
Institutional Investors Weigh In On Tempus AI
A number of hedge funds have recently modified their holdings of TEM. Vanguard Group Inc. increased its position in Tempus AI by 8.7% during the fourth quarter. Vanguard Group Inc. now owns 10,258,621 shares of the company's stock worth $605,772,000 after purchasing an additional 817,014 shares during the last quarter. ARK Investment Management LLC boosted its holdings in Tempus AI by 5.3% in the 4th quarter. ARK Investment Management LLC now owns 7,557,583 shares of the company's stock valued at $446,275,000 after purchasing an additional 381,816 shares during the last quarter. GC Wealth Management RIA LLC purchased a new stake in shares of Tempus AI in the 4th quarter valued at approximately $399,267,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Tempus AI by 23.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,326,313 shares of the company's stock worth $195,636,000 after buying an additional 821,490 shares during the last quarter. Finally, Amova Asset Management Americas Inc. increased its holdings in shares of Tempus AI by 23.4% during the 1st quarter. Amova Asset Management Americas Inc. now owns 4,326,313 shares of the company's stock worth $195,549,000 after buying an additional 821,490 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.
Tempus AI Company Profile
(
Get Free Report)
Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.
The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
